ARx is excited to present its poster, “Comparative Permeation Study of A Novel Buprenorphine Transmucosal Dosage Form versus Sublingual Tablet & Buccal Film” at AAPS Pharm Sci360 on Wednesday, Nov 7th at 9:30-10:30am. The poster demonstrates the rapid onset and bioavailability benefits of an optimized thin film product. Visit us at Booth 1711 to learn more.